NCT00749892 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- groups
- description
- Erlotinib 150 mg by mouth daily for 3 weeks followed by cystectomy within 24 hours of the last dose.
- id
- BG000
- title
- Pre-surgical Erlotinib Treatment
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 53
- upper Limit
- 86
- value
- 68
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 26
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 12
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 30
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 34
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cTaN0
- categories
- measurements
- group Id
- BG000
- value
- 10
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT1N0
- categories
- measurements
- group Id
- BG000
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT2N0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT3aN0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT3bN0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT4aN0
- description
- Participants were staged clinically before treatment began. The T describes the tumor size; the larger the number is the more advanced the disease. The N indicates the lymphnode involvement; zero indicates that no lymph nodes were believed to be cancerous.
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Three particpants withdrew from study treatment.
- title
- Clinical Staging
- unit Of Measure
- Participants
- population Description
- Participants were stagged clinically before treatment began. The T discribes the tumor size; the larger the number is the more advanced the disease. The N indicates the lymphpnode involvemnt; zero indicates that no lymph nodes were believed to be cancerous.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- groups
- description
- Erlotinib 150 mg by mouth daily for 3 weeks followed by cystectomy within 24 hours of the last dose.
- id
- BG000
- title
- Pre-surgical Erlotinib Treatment
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 53
- upper Limit
- 86
- value
- 68
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 26
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 12
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 21
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 30
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown or Not Reported
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 34
- denoms
- counts
- group Id
- BG000
- value
- 34
- units
- Participants
- title
- United States
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cTaN0
- categories
- measurements
- group Id
- BG000
- value
- 10
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT1N0
- categories
- measurements
- group Id
- BG000
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT2N0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT3aN0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT3bN0
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 31
- units
- Participants
- title
- cT4aN0
- description
- Participants were staged clinically before treatment began. The T describes the tumor size; the larger the number is the more advanced the disease. The N indicates the lymphnode involvement; zero indicates that no lymph nodes were believed to be cancerous.
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Three particpants withdrew from study treatment.
- title
- Clinical Staging
- unit Of Measure
- Participants
- population Description
- Participants were stagged clinically before treatment began. The T discribes the tumor size; the larger the number is the more advanced the disease. The N indicates the lymphpnode involvemnt; zero indicates that no lymph nodes were believed to be cancerous.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle